Safety and feasibility of dobutamine stress cardiac magnetic resonance for cardiovascular assessment prior to renal transplantation
| Autor: | Nick G. Bellenger, Oliver E. Gosling, Jason Moore, Angela C. Shore, Rebecca R. Chawner, David P Ripley, Sri Kannoly, Ejaz Hossain |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Adult
Male medicine.medical_specialty Cardiotonic Agents medicine.medical_treatment Population Autosomal dominant polycystic kidney disease Magnetic Resonance Imaging Cine Risk Assessment Ventricular Function Left Peritoneal dialysis Coronary artery disease Dobutamine Internal medicine Preoperative Care medicine Humans education Kidney transplantation Aged education.field_of_study business.industry General Medicine Middle Aged medicine.disease Kidney Transplantation Transplantation Cardiovascular Diseases Cardiology Feasibility Studies Kidney Failure Chronic Female Cardiology and Cardiovascular Medicine business Kidney disease medicine.drug |
| Zdroj: | Journal of Cardiovascular Medicine. 15:288-294 |
| ISSN: | 1558-2027 |
| DOI: | 10.2459/jcm.0000000000000029 |
| Popis: | Aims Current guidelines recommend cardiovascular risk assessment prior to renal transplantation. There is currently no evidence for the role of cardiovascular magnetic resonance (CMR) in this population, despite an established evidence base in the non-chronic kidney disease (CKD) population. Our aim is to determine the feasibility and safety of dobutamine stress CMR (DSCMR) imaging in the risk stratification of CKD patients awaiting renal transplantation. Methods CKD patients who were deemed at high risk for coronary artery disease (CAD) and awaiting renal transplantation underwent DSCMR. Results Forty-one patients whose median age was 56 years (range 28–73 years) underwent DSCMR. Nineteen were undergoing haemodialysis, 10 peritoneal dialysis and 12 pre-dialysis. The aetiology of the renal failure was diabetes mellitus in 29%, glomerulonephritis in 24%, hypertension in 22% and autosomal dominant polycystic kidney disease in 10%. Thirty-eight patients (93%) achieved the end point, either positive for ischaemia or negative, achieving at least 85% of age-predicted heart rate. Two of them did not achieve target heart rate and one was discontinued because of severe headache. Of the 38 patients who achieved the end point, 35 (92%) were negative for inducible wall motion abnormalities and four (10%) were positive. There were no serious adverse effects. Conclusion DSCMR is a well tolerated and viable investigation for the cardiovascular risk stratification of high-risk CKD patients prior to renal transplantation. DSCMR already has an established evidence base in the non-CKD population with superiority over other noninvasive techniques. Larger studies with outcome data are now required to define its true utility in the CKD population. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|